APA (7th ed.) Citation

PJ, J., X, S., AA, A., PT, W., K, J., RJ, E., . . . IS, G. (2025). Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity. Journal of virology, 99(12), e0125625. https://doi.org/10.1128/jvi.01256-25

Chicago Style (17th ed.) Citation

PJ, Jamieson, et al. "Glycan-reactive Antibodies Isolated from Human HIV-1 Vaccine Trial Participants Show Broad Pathogen Cross-reactivity." Journal of Virology 99, no. 12 (2025): e0125625. https://doi.org/10.1128/jvi.01256-25.

MLA (9th ed.) Citation

PJ, Jamieson, et al. "Glycan-reactive Antibodies Isolated from Human HIV-1 Vaccine Trial Participants Show Broad Pathogen Cross-reactivity." Journal of Virology, vol. 99, no. 12, 2025, p. e0125625, https://doi.org/10.1128/jvi.01256-25.